Peter Friedmann to United States
This is a "connection" page, showing publications Peter Friedmann has written about United States.
Connection Strength
2.373
-
Romo E, Stopka TJ, Jesdale BM, Wang B, Mazor KM, Friedmann PD. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States. Harm Reduct J. 2024 01 28; 21(1):23.
Score: 0.087
-
Park SE, Mosley JE, Grogan CM, Pollack HA, Humphreys K, D'Aunno T, Friedmann PD. Patient-centered care's relationship with substance use disorder treatment utilization. J Subst Abuse Treat. 2020 11; 118:108125.
Score: 0.069
-
Abraham AJ, Andrews CM, Harris SJ, Friedmann PD. Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA. Neurotherapeutics. 2020 01; 17(1):55-69.
Score: 0.065
-
Soares WE, Knowles KJ, Friedmann PD. A Thousand Cuts: Racial and Ethnic Disparities in Emergency Medicine. Med Care. 2019 12; 57(12):921-923.
Score: 0.065
-
Park SE, Grogan CM, Mosley JE, Humphreys K, Pollack HA, Friedmann PD. Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics. Psychiatr Serv. 2020 01 01; 71(1):35-42.
Score: 0.064
-
Abraham AJ, Smith BT, Andrews CM, Bersamira CS, Grogan CM, Pollack HA, Friedmann PD. Changes in State Technical Assistance Priorities and Block Grant Funds for Addiction After ACA Implementation. Am J Public Health. 2019 06; 109(6):885-891.
Score: 0.062
-
Andrews CM, Pollack HA, Abraham AJ, Grogan CM, Bersamira CS, D'Aunno T, Friedmann PD. Medicaid coverage in substance use disorder treatment after the affordable care act. J Subst Abuse Treat. 2019 07; 102:1-7.
Score: 0.062
-
Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 03; 109(3):434-436.
Score: 0.061
-
Andrews CM, Grogan CM, Smith BT, Abraham AJ, Pollack HA, Humphreys K, Westlake MA, Friedmann PD. Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act. Health Aff (Millwood). 2018 08; 37(8):1216-1222.
Score: 0.059
-
Andrews CM, Grogan CM, Westlake MA, Abraham AJ, Pollack HA, D'Aunno TA, Friedmann PD. Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study. J Subst Abuse Treat. 2018 04; 87:50-55.
Score: 0.057
-
Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatr Serv. 2018 04 01; 69(4):448-455.
Score: 0.057
-
Friedmann PD, Dunn KE, Nunes EV, O'Brien CP. Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT. J Subst Abuse Treat. 2018 02; 85:31-33.
Score: 0.057
-
Soares WE, Wilson D, Rathlev N, Lee JD, Gordon M, Nunes EV, O'Brien CP, Friedmann PD. Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual. J Subst Abuse Treat. 2018 02; 85:66-69.
Score: 0.055
-
D'Aunno T, Pollack H, Chen Q, Friedmann PD. Linkages Between Patient-centered Medical Homes and Addiction Treatment Organizations: Results From a National Survey. Med Care. 2017 04; 55(4):379-383.
Score: 0.054
-
Friedmann PD, Andrews CM, Humphreys K. How ACA Repeal Would Worsen the Opioid Epidemic. N Engl J Med. 2017 Mar 09; 376(10):e16.
Score: 0.054
-
Abraham AJ, Andrews CM, Grogan CM, D'Aunno T, Humphreys KN, Pollack HA, Friedmann PD. The Affordable Care Act Transformation of Substance Use Disorder Treatment. Am J Public Health. 2017 01; 107(1):31-32.
Score: 0.053
-
Grogan CM, Andrews C, Abraham A, Humphreys K, Pollack HA, Smith BT, Friedmann PD. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health Aff (Millwood). 2016 12 01; 35(12):2289-2296.
Score: 0.053
-
Mitchell SG, Willet J, Monico LB, James A, Rudes DS, Viglione J, Schwartz RP, Gordon MS, Friedmann PD. Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices. Subst Abus. 2016; 37(1):127-33.
Score: 0.050
-
Andrews C, Abraham A, Grogan CM, Pollack HA, Bersamira C, Humphreys K, Friedmann P. Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform. Health Aff (Millwood). 2015 May; 34(5):828-35.
Score: 0.047
-
Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. R I Med J (2013). 2014 Oct 01; 97(10):20-4.
Score: 0.046
-
Green TC, Johnson J, Harrington M, Pouget ER, Rhodes AG, Taxman FS, O'Connell DJ, Martin SS, Prendergast M, Friedmann PD. Parole officer-parolee relationships and HIV risk behaviors during community supervision. AIDS Behav. 2013 Oct; 17(8):2667-75.
Score: 0.042
-
D'Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014 Feb; 49(1):230-48.
Score: 0.042
-
Green TC, Pouget ER, Harrington M, Taxman FS, Rhodes AG, O'Connell D, Martin SS, Prendergast M, Friedmann PD. Limiting options: sex ratios, incarceration rates, and sexual risk behavior among people on probation and parole. Sex Transm Dis. 2012 Jun; 39(6):424-30.
Score: 0.039
-
Tseng VL, Greenberg PB, Wu WC, Jiang L, Li E, Kang JM, Scott IU, Friedmann PD. Cataract surgery complications in nonagenarians. Ophthalmology. 2011 Jul; 118(7):1229-35.
Score: 0.036
-
Greenberg PB, Tseng VL, Wu WC, Liu J, Jiang L, Chen CK, Scott IU, Friedmann PD. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology. 2011 Mar; 118(3):507-14.
Score: 0.035
-
Greenberg PB, Liu J, Wu WC, Jiang L, Tseng VL, Scott IU, Friedmann PD. Predictors of mortality within 90 days of cataract surgery. Ophthalmology. 2010 Oct; 117(10):1894-9, 1899.e1.
Score: 0.034
-
Friedmann PD, Jiang L, Alexander JA. Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs. J Behav Health Serv Res. 2010 Jul; 37(3):322-37.
Score: 0.031
-
Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat. 2008 Mar; 34(2):165-72.
Score: 0.027
-
Friedmann PD, Taxman FS, Henderson CE. Evidence-based treatment practices for drug-involved adults in the criminal justice system. J Subst Abuse Treat. 2007 Apr; 32(3):267-77.
Score: 0.027
-
Friedmann PD, Alexander JA, Yey Y, Nahra T, Soliman S, Pollack HA. Duration of nonmethadone outpatient treatment: results from a national survey. Subst Abus. 2006 Sep; 27(3):47-53.
Score: 0.026
-
Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006 Jan; 44(1):8-15.
Score: 0.025
-
Mixson LS, Zule W, Ruderman SA, Feinberg J, Stopka TJ, Sibley AL, Walters SM, Bobashev G, Cook R, Hochstatter KR, Fahey CA, Ouellet LJ, Fredericksen R, Cooper HLF, Young AM, Zibbell J, Khoury D, Friedmann PD, Miller WC, Korthuis PT, Westergaard RP, Whitney BM, Tsui JI, Crane HM, Delaney J. Prevalence and correlates of multiple injections per injection episode among people who inject drugs in rural U.S. communities. Int J Drug Policy. 2025 Sep; 143:104837.
Score: 0.024
-
Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, Friedmann PD. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005 Sep; 82(3):411-9.
Score: 0.024
-
Mixson LS, Venkataraman A, Drumright LN, Whitney BM, Jenkins WD, Friedmann PD, Zule WA, Havens J, Ruderman SA, Stopka TJ, Korthuis PT, Pho MT, Westergaard RP, Seal DW, Go VF, Miller WC, Feinberg J, Smith G, Tsui JI, Delaney JA, Crane HM. Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative. Subst Use Addctn J. 2025 Oct; 46(4):847-858.
Score: 0.024
-
Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA. Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2025 04 01; 8(4):e255340.
Score: 0.024
-
Jenkins WD, Beach LB, Schneider J, Friedman SR, Pho MT, Walters S, Ezell J, Young AM, Hennessy C, Miller WC, Go VF, Sun C, Seal DW, Westergaard RP, Crane HM, Fredericksen RJ, Ruderman SA, Fletcher S, Ma J, Delaney JA, Plaisance K, Feinberg J, Smith GS, Korthuis PT, Stopka TJ, Friedmann PD, Zule W, Winer M. Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S. J Subst Use Addict Treat. 2025 Apr; 171:209629.
Score: 0.023
-
Jenkins WD, Pho MT, Nance RM, Young AM, Zule W, Stopka TJ, Friedmann PD, Miller WC, Go VF, Korthuis PT, Westergaard R, Seal DW, Feinberg J, Smith GS, Crane HM, Tsui JI, Lanter T, Choudhary V. Influence of insurance type on healthcare utilization among rural people who use drugs. Drug Alcohol Depend. 2025 Apr 01; 269:112542.
Score: 0.023
-
Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
Score: 0.023
-
Stopka TJ, Whitney BM, de Gijsel D, Brook DL, Friedmann PD, Taylor LE, Feinberg J, Young AM, Evon DM, Herink M, Westergaard R, Koepke R, Havens JR, Zule WA, Delaney JA, Pho MT. Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs. Med Care. 2025 Feb 01; 63(2):77-88.
Score: 0.023
-
Ballard AM, Kesich Z, Crane HM, Feinberg J, Friedmann PD, Go VF, Jenkins WD, Korthuis PT, Miller WC, Pho MT, Seal DW, Smith GS, Stopka TJ, Westergaard RP, Zule WA, Young AM, Cooper HL. Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative. Drug Alcohol Depend. 2025 Jan 01; 266:112498.
Score: 0.023
-
Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2024 09 03; 7(9):e2434704.
Score: 0.023
-
Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z. The effect of matching comprehensive services to patients' needs on drug use improvement in addiction treatment. Addiction. 2004 Aug; 99(8):962-72.
Score: 0.022
-
Fredericksen RJ, Mixson LS, Estadt AT, Leichtling G, Bresett J, Zule W, Walters SM, Friedmann PD, Romo E, Whitney BM, Delaney JAC, Crane HM, Tsui JI, Young A, Seal D, Stopka TJ. Barriers to retention in inpatient and residential drug treatment among persons who use opioids and/or injection drugs living in the rural U.S. J Subst Use Addict Treat. 2024 Oct; 165:209453.
Score: 0.022
-
Prusaczyk B, Tilmon S, Landman J, Seibert D, Colston DC, Westergaard R, Cooper H, Feinberg J, Friedmann PD, Go VF, Khoury D, Korthius T, Mixson S, Moellner A, Nolte K, Smith G, Young A, Pho MT, Jenkins W. Barriers to Healthcare and Social Service Utilization Among Rural Older Adults Who Use Drugs. J Appl Gerontol. 2024 12; 43(12):1977-1984.
Score: 0.022
-
Stopka TJ, Estadt AT, Leichtling G, Schleicher JC, Mixson LS, Bresett J, Romo E, Dowd P, Walters SM, Young AM, Zule W, Friedmann PD, Go VF, Baker R, Fredericksen RJ. Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study. Soc Sci Med. 2024 04; 346:116660.
Score: 0.022
-
Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z. Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs. J Behav Health Serv Res. 2004 Jan-Mar; 31(1):86-97.
Score: 0.022
-
Estadt AT, Miller WC, Kline D, Whitney BM, Young AM, Todd Korthuis P, Stopka TJ, Feinberg J, Zule WA, Pho MT, Friedmann PD, Westergaard RP, Eagen KV, Seaman A, Ma J, Go VF, Lancaster KE. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. Int J Drug Policy. 2025 Jul; 141:104222.
Score: 0.021
-
Warner EA, Walker RM, Friedmann PD. Should informed consent be required for laboratory testing for drugs of abuse in medical settings? Am J Med. 2003 Jul; 115(1):54-8.
Score: 0.021
-
Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003 Jun; 38(3):887-903.
Score: 0.021
-
Friedmann PD, Lemon SC, Anderson BJ, Stein MD. Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). Drug Alcohol Depend. 2003 Apr 01; 69(3):243-51.
Score: 0.021
-
Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003 Jan; 18(1):1-8.
Score: 0.020
-
Friedmann PD, Herman DS, Freedman S, Lemon SC, Ramsey S, Stein MD. Treatment of sleep disturbance in alcohol recovery: a national survey of addiction medicine physicians. J Addict Dis. 2003; 22(2):91-103.
Score: 0.020
-
Elliott L, Nerney M, Jones T, Friedmann PD. Barriers to screening for domestic violence. J Gen Intern Med. 2002 Feb; 17(2):112-6.
Score: 0.019
-
Stein MD, Friedmann PD. Generalist physicians and addiction care: from turfing to sharing the turf. JAMA. 2001 Oct 10; 286(14):1764-5.
Score: 0.019
-
Friedmann PD, Lemon SC, Stein MD, Etheridge RM, D'Aunno TA. Linkage to medical services in the Drug Abuse Treatment Outcome Study. Med Care. 2001 Mar; 39(3):284-95.
Score: 0.018
-
Friedmann PD, Saitz R, Gogineni A, Zhang JX, Stein MD. Validation of the screening strategy in the NIAAA "Physicians' Guide to Helping Patients with Alcohol Problems". J Stud Alcohol. 2001 Mar; 62(2):234-8.
Score: 0.018
-
Friedmann PD, McCullough D, Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med. 2001 Jan 22; 161(2):248-51.
Score: 0.018
-
Friedmann PD, D'Aunno TA, Jin L, Alexander JA. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res. 2000 Jun; 35(2):443-65.
Score: 0.017
-
Friedmann PD, McCullough D, Chin MH, Saitz R. Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists. J Gen Intern Med. 2000 Feb; 15(2):84-91.
Score: 0.016
-
Shover CL, Abraham A, D'Aunno T, Friedmann PD, Humphreys K. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs. J Subst Abuse Treat. 2019 10; 105:44-50.
Score: 0.016
-
Fisher JE, Friedmann P. The longitudinal study of surgical residents 1994-1996. J Am Coll Surg. 1999 Jun; 188(6):676-7.
Score: 0.016
-
Friedmann PD, Alexander JA, Jin L, D'Aunno TA. On-site primary care and mental health services in outpatient drug abuse treatment units. J Behav Health Serv Res. 1999 Feb; 26(1):80-94.
Score: 0.015
-
Bliton J, Muscarella P, Friedmann P, Parides M, Papalezova K, McAuliffe JC, In H. Perioperative Mortality Does Not Explain Racial Disparities in Gastrointestinal Cancer. J Gastrointest Surg. 2019 08; 23(8):1631-1642.
Score: 0.015
-
McCall JL, Macchiaroli S, Brown RB, Schulte MJ, Calderone S, Selbovitz LG, Corl AM, Reed WP, Friedmann P. A method to track surgical site infections. Qual Manag Health Care. 1998; 6(3):52-62.
Score: 0.014
-
Tran Smith B, Seaton K, Andrews C, Grogan CM, Abraham A, Pollack H, Friedmann P, Humphreys K. Benefit requirements for substance use disorder treatment in state health insurance exchanges. Am J Drug Alcohol Abuse. 2018; 44(4):426-430.
Score: 0.014
-
Christopher PP, Stein MD, Johnson JE, Rich JD, Friedmann PD, Clarke J, Lidz CW. Exploitation of Prisoners in Clinical Research: Perceptions of Study Participants. IRB. 2016 Jan-Feb; 38(1):7-12.
Score: 0.012
-
D'Aunno T, Friedmann PD, Chen Q, Wilson DM. Integration of Substance Abuse Treatment Organizations into Accountable Care Organizations: Results from a National Survey. J Health Polit Policy Law. 2015 Aug; 40(4):797-819.
Score: 0.012
-
Lantini R, van den Berg JJ, Roberts MB, Bock BC, Stein LA, Parker DR, Friedmann PD, Clarke JG. Characteristics of smoking used cigarettes among an incarcerated population. Psychol Addict Behav. 2015 Mar; 29(1):254-8.
Score: 0.011
-
Wu WC, Jiang L, Friedmann PD, Trivedi A. Association between process quality measures for heart failure and mortality among US veterans. Am Heart J. 2014 Nov; 168(5):713-20.
Score: 0.011
-
Cupertino AP, Hunt JJ, Gajewski BJ, Jiang Y, Marquis J, Friedmann PD, Engelman KK, Richter KP. The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities. Subst Abuse Treat Prev Policy. 2013 Mar 15; 8:13.
Score: 0.010
-
Wu WC, Trivedi A, Friedmann PD, Henderson WG, Smith TS, Poses RM, Uttley G, Vezeridis M, Eaton CB, Mor V. Association between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates. Ann Surg. 2012 Apr; 255(4):708-14.
Score: 0.010
-
Pirraglia PA, Rowland E, Wu WC, Friedmann PD, O'Toole TP, Cohen LB, Taveira TH. Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness. Prev Chronic Dis. 2012; 9:E51.
Score: 0.009
-
Clarke JG, Martin RA, Stein L, Lopes CE, Mello J, Friedmann P, Bock B. Working Inside for Smoking Elimination (Project W.I.S.E.) study design and rationale to prevent return to smoking after release from a smoke free prison. BMC Public Health. 2011 Oct 05; 11:767.
Score: 0.009
-
Hunt JJ, Cupertino AP, Garrett S, Friedmann PD, Richter KP. How is tobacco treatment provided during drug treatment? J Subst Abuse Treat. 2012 Jan; 42(1):4-15.
Score: 0.009
-
Pirraglia PA, Kilbourne AM, Lai Z, Friedmann PD, O'Toole TP. Colocated general medical care and preventable hospital admissions for veterans with serious mental illness. Psychiatr Serv. 2011 May; 62(5):554-7.
Score: 0.009
-
Celoria G, Steingrub JS, Vickers-Lahti M, Teres D, Stein KL, Fink M, Friedmann P. Clinical assessment of hemodynamic values in two surgical intensive care units. Effects on therapy. Arch Surg. 1990 Aug; 125(8):1036-9.
Score: 0.009
-
Sacks S, Cleland CM, Melnick G, Flynn PM, Knight K, Friedmann PD, Prendergast ML, Coen C. Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS. Behav Sci Law. 2009 Jan-Feb; 27(1):51-69.
Score: 0.008
-
Rhodes AG, Taxman FS, Friedmann PD, Cropsey KL. HCV in incarcerated populations: an analysis of gender and criminality on risk. J Psychoactive Drugs. 2008 Dec; 40(4):493-501.
Score: 0.008
-
Vassilev ZP, Strauss SM, Astone JM, Friedmann PD, Des Jarlais DC. Provision of on-site medical care to patients with hepatitis C in drug treatment units. J Health Care Poor Underserved. 2004 Nov; 15(4):663-71.
Score: 0.006
-
Lubelczyk RA, Friedmann PD, Lemon SC, Stein MD, Gerstein DR. HIV prevention services in correctional drug treatment programs: do they change risk behaviors? AIDS Educ Prev. 2002 Apr; 14(2):117-25.
Score: 0.005
-
Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001 Jan 08; 161(1):85-91.
Score: 0.004
-
Bennett NL, Davis DA, Easterling WE, Friedmann P, Green JS, Koeppen BM, Mazmanian PE, Waxman HS. Continuing medical education: a new vision of the professional development of physicians. Acad Med. 2000 Dec; 75(12):1167-72.
Score: 0.004
-
Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997 Sep; 12(9):523-30.
Score: 0.003